10,000 results · 54ms · Sources: EU EUDAMED, US FDA

Exa Intrapol RA - weiss

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Intrapol RA - weiss

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Intrapol RA - weiss

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Dental RA - schwarz

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Dental RA - schwarz

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Dental RA - schwarz

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Dental RA - schwarz

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Dental RA - schwarz

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Dental RA - schwarz

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Cerapol RA - grau

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Cerapol RA - grau

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Cerapol RA - rosa

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Cerapol RA - rosa

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Cerapol RA - rosa

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Cerapol RA - rosa

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Cerapol RA - grau

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Cerapol RA - grau

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Cerapol RA - grau

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Exa Cerapol RA - grau

Device
EU MDR · Eu Md Class 2a ·Edenta Etablissement·On the market·1 country

Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions

FDA Pre-Market Approval
FDA Class 3 ·Access Hybritech Free PSA Reagents on the Access Immunoassay Systems